Arthur A. Levin, Chief Scientific Officer: Avidity Biosciences RNA Sell · Filed 23/01/17

Trade details

Type: Insider sale
Amount: $220,000
Shares · price: 10,000 sh · $22.00 a share
Held after: 1,330 sh
Stock: Avidity Biosciences RNA
Person: Arthur A. LevinChief Scientific Officer
Trade date: 23/01/12
Filed: 23/01/17
Days to filing: 5 days

Sold 88.3% of holdings

Share of holding sold: 88.3%

Avidity Biosciences trades, last 26 weeks

What else happened in Avidity Biosciences around then

Filed or reported within 30 days of the trade day · 22/12/13~23/02/11

Arthur A. Levin's recent trades

Arthur A. LevinDirector
Sell10b5-1 planStoke Therapeutics
Sell10b5-1 plan
Stoke Therapeutics
STOK
$22.3K
605 sh
$22.3K
Filed 03/17
Traded 03/13
Arthur A. LevinDirector
Planned sale10b5-1 planStoke Therapeutics
Planned sale10b5-1 plan
Stoke Therapeutics
STOK
$22.1K
605 sh
$22.1K
Filed 03/13
Traded 03/13
Arthur A. LevinDirector
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$127.4K
1,758 sh
$127.4K
Filed 01/23
Traded 01/21
Arthur A. LevinDirector
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$5.1M
107,500 sh
$5.1M
Filed 25/08/08
Traded 25/08/06
Arthur A. LevinDirector
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$53.5K
1,872 sh
$53.5K
Filed 25/01/23
Traded 25/01/21